U.S. Army Identifies ChemImage for the 2011 Commercialization Pilot Program
ChemImage Corporation is one of 25 companies recently identified to participate in the U.S. Army Small Business Innovation Research (SBIR) 2011 Commercialization Pilot Program (CPP) for its real-time chemometrics and sensor fusion (RTCSF) technology.
PITTSBURGH, Dec. 16, 2010 — ChemImage Corporation is one of 25 companies recently identified to participate in the U.S. Army Small Business Innovation Research (SBIR) 2011 Commercialization Pilot Program (CPP) for its real-time chemometrics and sensor fusion (RTCSF) technology.
Developed under a Phase II SBIR managed by the Army Research Office (ARO), ChemImage’s RTCSF technology will enable the real-time detection of chemical, biological and explosive threats. In 2011, the company will receive program support to accelerate its transition from research and development to commercial use.
“After rigorous analysis by U.S. Army SBIR, we’re pleased that the work being performed under the RTCSF project addresses high priority Army needs,” said Patrick Treado, PhD., Founder & Chief Technology Officer at ChemImage. “The support we’ll receive from the CPP will assist us in fielding this innovative ChemImage technology for use by Soldier Operators.”
Companies identified for CPP participation most strongly exemplify the program's mission goals of addressing high priority Army needs, exhibiting the potential for accelerated transition and offering high commercialization potential. Program assistance includes: business and transition plan development, potential investment needs planning and justification, and facilitation of meetings with potential private and/or government customers.
The U.S. Army established the SBIR CPP in 2007 in response to the 2006 National Defense Authorization Act, with the purpose of increasing SBIR technology transition and commercialization success.
For more information on ChemImage’s threat detection capabilities, visit http://www.chemimage.com/threat.
Media Contact:
Suzanne Cibotti
Sr. Marketing Communications Specialist
(412) 241-7335, ext. 291
cibottis@chemimage.com
About ChemImage
ChemImage Corporation, a leader in hyperspectral imaging technology (i.e., molecular chemical imaging), provides instrumentation, software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art Hyperspectral Imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage’s headquarters are located in Pittsburgh, Pa., where it houses research and development laboratories, as well as engineering and manufacturing facilities.
Tags: